Cempra to Participate in Jefferies 2015 Antibiotic Summit Investor Conference
March 16, 2015 17:21 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., March 16, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
February 25, 2015 16:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Fourth Quarter and Full Year 2014 Financial Results
February 17, 2015 08:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Present at Three Upcoming Investor Conferences
February 03, 2015 08:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Announces Full Exercise of Additional Share Option and Completion of the Public Offering of Common Stock
January 13, 2015 16:01 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Prices Public Offering of Common Stock
January 07, 2015 20:00 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Announces Positive Topline Phase 3 Clinical Results for Oral Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
January 04, 2015 17:00 ET
|
Melinta Therapeutics, Inc.
Solithromycin met the primary and secondary objectives of non-inferiority compared to moxifloxacin
Cempra to host webcast and conference call on January 5, 2015 at 8:00 a.m. EST
CHAPEL HILL,...
Cempra to Present at Two Upcoming Investor Conferences
November 10, 2014 16:05 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update
October 29, 2014 16:05 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
Cempra to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on October 29, 2014
October 22, 2014 07:30 ET
|
Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...